| Prev Close: | 8.17 |
|---|---|
| Open: | N/A |
| Bid: | 8.01 x 200 |
| Ask: | 8.58 x 500 |
| 1y Target Est: | 11.50 |
| Beta: | 1.8 |
| Next Earnings Date: | 5-Aug-13 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 6.92 - 17.48 |
| Volume: | 0 |
| Avg Vol (3m): | 1,000,230 |
| Market Cap: | 483.51M |
| P/E (ttm): | 11.44 |
| EPS (ttm): | 0.71 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 3 Reasons You Shouldn't Buy Stocks in Biotechat Motley Fool(Thu, Jun 13)
- Spectrum Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 08:00 AMat Seeking Alpha(Tue, Jun 11)
- Spectrum Pharma Picks New CFOat Motley Fool(Thu, Jun 6)
- Spectrum Pharmaceuticals to Present Corporate Update at the Goldman Sachs 34th Annual Global Healthcare Conference in Rancho Palos Verdes on June 11thBusiness Wire(Thu, Jun 6)
- CFO Moves: CBS, Spectrum Pharmaceuticals, Mad Catz Interactiveat The Wall Street Journal(Wed, Jun 5)
- Spectrum Pharma names Gustafson as new CFOAP(Wed, Jun 5)
- Spectrum Pharmaceuticals Further Strengthens Management; Announces Appointment of Kurt Gustafson as Executive Vice President, Chief Financial Officer and Principal Accounting OfficerBusiness Wire(Wed, Jun 5)
- SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements andEDGAR Online(Wed, Jun 5)
- Spectrum announces positive data from BELIEF trial presented at ASCOtheflyonthewall.com(Mon, Jun 3)
- Spectrum Pharmaceuticals Announces Positive Data from the BELIEF Trial Presented at the 2013 American Society of Clinical Oncology (ASCO) Annual MeetingBusiness Wire(Mon, Jun 3)
- SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Sun, Jun 2)
- 5 Worst Biotechs of 2013at Motley Fool(Fri, May 31)
- Spectrum to present six abstracts of clinical data at ASCOtheflyonthewall.com(Fri, May 31)
- Spectrum Pharmaceuticals Highlights Six Abstracts of Clinical Data at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 31 – June 4, 2013Business Wire(Fri, May 31)
- Spectrum Pharmaceuticals' Management Presents at 38th Annual Deutsche Bank Health Care Conference (Transcript)at Seeking Alpha(Thu, May 30)
Press Releases
- Spectrum Pharmaceuticals to Present Corporate Update at the Goldman Sachs 34th Annual Global Healthcare Conference in Rancho Palos Verdes on June 11thBusiness Wire(Thu, Jun 6)
- Spectrum Pharmaceuticals Further Strengthens Management; Announces Appointment of Kurt Gustafson as Executive Vice President, Chief Financial Officer and Principal Accounting OfficerBusiness Wire(Wed, Jun 5)
- Spectrum Pharmaceuticals Announces Positive Data from the BELIEF Trial Presented at the 2013 American Society of Clinical Oncology (ASCO) Annual MeetingBusiness Wire(Mon, Jun 3)
Reports
- SPPI: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Jun 19)
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(Jun 19)
- SPPI - Spectrum Pharmaceuticals Inc - Rated a Hold - Company Analysis and ASR...Alpha Street Research(Jun 18)